Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: the UK Transcatheter Aortic Valve Implantation …
A Duncan, P Ludman, W Banya, D Cunningham… - JACC: Cardiovascular …, 2015 - jacc.org
Abstract Objectives: The UK Transcatheter Aortic Valve Implantation Registry reported 30-
day and 1-year mortality rates of 7.1% and 21.4%, respectively, for patients who underwent …
day and 1-year mortality rates of 7.1% and 21.4%, respectively, for patients who underwent …
Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom Transcatheter Aortic …
NE Moat, P Ludman, MA De Belder… - Journal of the American …, 2011 - jacc.org
Objectives: The objective was to define the characteristics of a real-world patient population
treated with transcatheter aortic valve implantation (TAVI), regardless of technology or …
treated with transcatheter aortic valve implantation (TAVI), regardless of technology or …
Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial)
SK Kodali, WW O'Neill, JW Moses, M Williams… - The American journal of …, 2011 - Elsevier
Transcatheter aortic valve implantation (TAVI) with the Cribier-Edwards prosthesis may
provide an alternative to conventional aortic valve replacement in high-risk patients with …
provide an alternative to conventional aortic valve replacement in high-risk patients with …
Late outcomes of transcatheter aortic valve replacement in high-risk patients: the FRANCE-2 registry
M Gilard, H Eltchaninoff, P Donzeau-Gouge… - Journal of the American …, 2016 - jacc.org
Background: Transcatheter aortic valve replacement (TAVR) has revolutionized
management of high-risk patients with severe aortic stenosis. However, survival and the …
management of high-risk patients with severe aortic stenosis. However, survival and the …
Outcomes 2 years after transcatheter aortic valve replacement in patients at low surgical risk
MB Leon, MJ Mack, RT Hahn, VH Thourani… - Journal of the American …, 2021 - jacc.org
Background In low surgical risk patients with symptomatic severe aortic stenosis, the
PARTNER 3 (Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low …
PARTNER 3 (Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low …
3-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis
JK Forrest, GM Deeb, SJ Yakubov, H Gada… - Journal of the American …, 2023 - jacc.org
Background Randomized data comparing outcomes of transcatheter aortic valve
replacement (TAVR) with surgery in low–surgical risk patients at time points beyond 2 years …
replacement (TAVR) with surgery in low–surgical risk patients at time points beyond 2 years …
Self-expanding transcatheter vs surgical aortic valve replacement in intermediate-risk patients: 5-year outcomes of the SURTAVI randomized clinical trial
NM Van Mieghem, GM Deeb, L Søndergaard… - JAMA …, 2022 - jamanetwork.com
Importance In patients with severe aortic valve stenosis at intermediate surgical risk,
transcatheter aortic valve replacement (TAVR) with a self-expanding supra-annular valve …
transcatheter aortic valve replacement (TAVR) with a self-expanding supra-annular valve …
Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis
R Zahn, U Gerckens, A Linke, H Sievert… - The American journal of …, 2013 - Elsevier
Transcatheter aortic valve implantation (TAVI) is already an accepted option to treat elderly
patients with severe symptomatic aortic stenosis who are inoperable or at high surgical risk …
patients with severe symptomatic aortic stenosis who are inoperable or at high surgical risk …
In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: data from the TAVI National Registry 2010-2011
M Sabate, S Canovas, E García, RH Antolín… - Revista Española de …, 2013 - Elsevier
Introduction and objectives The treatment of severe symptomatic aortic stenosis has been
revolutionized by the technique of transcatheter valve replacement. The purpose of this …
revolutionized by the technique of transcatheter valve replacement. The purpose of this …
5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised …
SR Kapadia, MB Leon, RR Makkar, EM Tuzcu… - The Lancet, 2015 - thelancet.com
Background Based on the early results of the Placement of Aortic Transcatheter Valves
(PARTNER) trial, transcatheter aortic valve replacement (TAVR) is an accepted treatment for …
(PARTNER) trial, transcatheter aortic valve replacement (TAVR) is an accepted treatment for …